Looking into the "Garden of the Hesperides": new drugs for hepatocellular carcinoma
Castañón Alvarez E (1), Giallombardo M, Gil-Bazo I, Papadimitriou K, Pauwels P, Peeters M, Rolfo C.
(1) Department of Oncology, Clínica Universidad de Navarra Pamplona, Spain
Magazine: Minerva Chirurgica
Date: Apr 1, 2015Medical Oncology
Advanced hepatocellular carcinoma remains an entity that is hard to approach therapeutically and has shown disappointing results in terms of survival. For many years, the only accepted option for this setting was the use of a multikinase inhibitor, sorafenib. Nevertheless, through the years, a deeper knowledge has arisen about how pathogenic pathways correlate with hepatocellular carcinoma. In this review, we provide an update of the most recent data regarding new agents under investigation and new possible targets for future treatments.
CITATION Minerva Chir. 2015 Apr;70(2):119-29. Epub 2015 Jan 23
you maybe interested
The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.
The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.
Learn why we are different from other healthcare centers. Quality, speed, comfort and results.